Next Article in Journal
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Next Article in Special Issue
Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection
Previous Article in Journal
Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era
 
 
Review

Article Versions Notes

Vaccines 2023, 11(3), 681; https://doi.org/10.3390/vaccines11030681
Action Date Notes Link
article xml file uploaded 17 March 2023 07:12 CET Original file -
article xml uploaded. 17 March 2023 07:12 CET Update https://www.mdpi.com/2076-393X/11/3/681/xml
article pdf uploaded. 17 March 2023 07:12 CET Version of Record https://www.mdpi.com/2076-393X/11/3/681/pdf
article supplementary file uploaded. 17 March 2023 07:12 CET - https://www.mdpi.com/2076-393X/11/3/681#supplementary
article html file updated 17 March 2023 07:13 CET Original file -
article html file updated 6 April 2023 20:23 CEST Update https://www.mdpi.com/2076-393X/11/3/681/html
Back to TopTop